Table 2.
Characteristic | aHR | SE | 95% CI | P-value | |
---|---|---|---|---|---|
1 | Age category | ||||
<60 | (Ref.) | ||||
≥60 | 2.19 | 0.66 | 1.22–3.95 | 0.009 | |
2 | Gender | ||||
Female | (Ref.) | ||||
Male | 4.36 | 2.61 | 1.34–14.11 | 0.01 | |
3 | Karnofsky | ||||
Able to carry normal activity and work | (Ref.) | ||||
Unable to work, able to live at home | 4.48 | 2.69 | 1.38–14.52 | 0.01 | |
4 | DM status | ||||
Absent | (Ref.) | ||||
Present | 0.42 | 0.16 | 0.20–0.90 | 0.02 | |
5 | Anemia | ||||
Present | 2.30 | 1.01 | 0.97–5.44 | 0.06 | |
Absent | (Ref.) | ||||
6 | Leukopenia | ||||
Present | 3.54 | 1.87 | 1.25–9.99 | 0.02 | |
Absent | (Ref.) | ||||
7 | Thrombocytopenia | ||||
Present | 3.32 | 1.99 | 1.02–10.80 | 0.04 | |
Absent | (Ref.) | ||||
8 | High NLR | ||||
Present | 3.18 | 1.04 | 1.68–6.04 | <0.001 | |
Absent | (Ref.) |
Effect measurements—aHR with its standard error (SE), 95% CI and corresponding P-value—from predictive model. Bold values indicate P-value is statistically significant.